Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Obstetrics/Gynecology
Clinical Trials: Cervical Intraepithelial Neoplasia
A listing of clinical trials currently looking for volunteers to enroll in Cervical Intraepithelial Neoplasia studies. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Chandler : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Chandler : New Horizons Women's Care, LLC
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Phoenix : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Phoenix : Precision Trials
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Phoenix : Arizona OB/GYN Affiliates, PC
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
View More »
Tucson : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Tucson : Visions Clinical Research - Tucson
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
California
Colton : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
La Mesa : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
La Mesa : Grossmont Center for Clinical Research
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Florida
Lake Worth : Altus Research
Vaccine for Patients Who Have an Abnormal PAP Smear (Cervical Intraepithelial Neoplasia Grade 2 or 3)
View More »
Boynton Beach : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Boynton Beach : Visions Clinical Research
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Lake Worth : Altus Research
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Sarasota : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Illinois
Chicago : Center for Women
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Maryland
Baltimore : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
New York
Bronx : Biomedical Research Alliance of New York
Cervical Intraepithelial Neoplasia (CIN) - Females
View More »
Bronx : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Bronx : Montefiore Medical Center
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
New York : New York Downtown Hospital
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Port Jefferson : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
North Carolina
Winston-Salem : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Ohio
Englewood : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Oklahoma
Oklahoma city : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Oregon
Eugene : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Pennsylvania
Philadelphia : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
South Carolina
Columbia : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Mrytle Beach : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Texas
San Antonio : InVisions Consultants, LLC
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
San Antonio : InVisions Consultants, LLC- c/o Institute for Women's Health
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Utah
Murray : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Salt Lake City : Wasatch Clinical Research
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
Sandy : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Virginia
Richmond : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Washington
Renton : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Australia
Victoria : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Belgium
Bruxelles : Hôpital Erasme
Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)
Bruxelles : Hôpital Saint Pierre
Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)
Bruxelles : CHU Brugmann
Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)
Ixelles : HIS Ixelles
Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)
Liege : CHR Citadelle
Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)
China
Nanjing : Jiangsu Provincial Centre for Disease Control and Prevention
Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine
France
Lille : Department of Obstetrics and Gyneacology, Lille University Hospital
Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1
Japan
Tokyo : MSD K.K.
V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)
Korea, Republic of
Seoul : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
Norway
Larvik : Fritzøe klinikk
Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1
Trondheim : Medicus
Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 1
South Africa
Cape Town : Updated
A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3
